Historically, medium-priority insider buys have outperformed the S&P 500 by a median ~1% over the 30 days after filing — the edge is concentrated in that first month (n ≈ 7,520, 2022-2026). Past results don't predict the future. How we measure this ↗
CFO Harrison Shane R purchases 8,000 NRC shares at $12.27; stock down 44.6% from 52-week high.
CFO Harrison Shane R purchased 8,000 shares at $12.27 on 2026-02-17 with no prior holdings, establishing an initial position worth $98.2K. The acquisition occurs against a backdrop of significant price deterioration: the stock is currently $12.45 (down 44.6% from its 52-week high of $22.48) and down 43.1% over the past 30 days. Revenue growth has turned negative at -3.7% year-over-year, though the company remains profitable with a P/E of 17.29 and market cap of $282.1M. The timing of this open-market purchase during a sharp downtrend and revenue contraction warrants observation of whether this represents the beginning of a position build or a one-time acquisition.
NRC CAO Freeman Jordan Nicole bought 771 shares at $12.97 on 2025-07-31, establishing first position (total value $9,999.87).
Freeman Jordan Nicole, the Chief Accounting Officer, made an open-market purchase of 771 shares at $12.97, establishing an initial stake in NATIONAL RESEARCH CORP. The transaction occurred at a price approximately $0.69 below the current price of $13.66 and significantly below the 52-week high of $26.17. The stock has declined 47.8% from its 52-week peak and dropped 19.7% over the past 30 days, suggesting the purchase occurred amid recent downward price movement. With the company trading at a P/E of 12.89 and posting net income of $5.8M on revenue of $33.6M, the purchase warrants attention as a potential signal of insider interest at lower valuations, though the modest position size and recent declines merit observation.
10% owner Patrick E. Beans bought 2,500 shares of NRC at $13.59; stock down 57.8% from 52-week high.
Patrick E. Beans, a 10% owner, purchased 2,500 shares at $13.59, increasing his holdings to 35,003 shares. The transaction occurs in a context of significant stock weakness: NRC is trading at $13.44, down 57.8% from its 52-week high of $31.84, though it has recovered 25.6% over the past 30 days. The company's fundamentals show modest deterioration with annual revenue declining 3.7%, though the P/E of 12.68 and recent modest quarterly results ($33.6M revenue, $5.8M net income) suggest the stock is trading at a relatively low valuation multiple. The buy occurs after a sharp drawdown and partial rebound, in a period of material price recovery, without any disclosed scheduled trading plan indicated in this filing.
Add NRC to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.
